Wednesday, July 9, 2014

Research and Markets Pharma Regulatory Affairs in Africa, Including South Africa Seminar, Dubai - 30th October 2014

Research and Markets Pharma Regulatory Affairs in Africa, Including South Africa Seminar, Dubai - 30th October 2014


. Buy General Detox online Levaquin (Levofloxacin) with free prescription Buy Lotemax (Loteprednol) with no Rx DUBLIN--(BUSINESS WIRE)--Research and Markets (.researchandmarkets.com/research/tjl4q6/pharma_regulatory) has announced the addition of the "Pharma Regulatory Affairs in Africa, Including South Africa (Seminar, Dubai)" conference to their offering. 30 October 2014 - Raffles Dubai Hotel, Dubai, UAE This seminar will be of particular interest to all those who need to learn about successful marketing authorisation applications and regulatory compliance in English speaking Africa. http://webmdhelp.wordpress.com Cabergoline with no Rx Buy Lotensin (Benazepril) with no Rx It will be useful as both an introductory or a refresher course on recent developments. TOPICS TO BE COVERED AT THIS MEETING: Gain an Overview of the Regulatory Requirements within English Speaking African countries Ensure you Understand Company and Product Registration Take away Practical tips on Compiling Dossiers Understand How to Comply with Regulatory Submission Strategy Clarify Recent Developments in South Africa Discuss Harmonisation and Co-operation Initiatives in Africa WHY SHOULD YOU ATTEND? This seminar will provide you with an essential overview of the key areas of pharmaceutical regulatory affairs in English speaking Africa. The aim of this seminar is to provide you with: An understanding of the key areas of regulatory affairs in the region A focus on the practical aspects to assist with regulatory activities The opportunity for you to participate in interactive discussions and exchange experiences with other delegates COUNTRIES COVERED DURING THIS MEETING Botswana Ethiopia Ghana Kenya Malawi Mozambique Namibia Nigeria South Africa Tanzania Uganda Zambia Zimbabwe A Certificate of Attendance for Professional Development will be given to each participant who completes the course For more information visit .researchandmarkets.com/research/tjl4q6/pharma_regulatory

No comments:

Post a Comment